Patents by Inventor Iain Watson

Iain Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interaction
    Patent number: 11518764
    Abstract: The present application relates to compounds of Formula I or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: December 6, 2022
    Assignee: ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
    Inventors: Rima Al-awar, Methvin Isaac, Anh My Chau, Ahmed Mamai, Iain Watson, Gennady Poda, Pandiaraju Subramanian, Brian Wilson, David Uehling, Michael Prakesch, Babu Joseph, Justin-Alexander Morin
  • Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof
    Patent number: 11242351
    Abstract: The present application relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: February 8, 2022
    Assignee: ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
    Inventors: Rima Al-awar, Methvin Isaac, Anh My Chau, Ahmed Mamai, Iain Watson, Gennady Poda, Pandiaraju Subramanian, Brian Wilson, David Uehling
  • TRICYCLIC INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND USES THEREOF
    Publication number: 20210053978
    Abstract: The present application relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.
    Type: Application
    Filed: December 21, 2018
    Publication date: February 25, 2021
    Applicant: Ontario Institute for Cancer Research (OICR)
    Inventors: Rima Al-awar, Methvin Isaac, Anh My Chau, Ahmed Mamai, Iain Watson, Gennady Poda, Pandiaraju Subramanian, Brian Wilson, David Uehling
  • Exhaust gas oxygen sensor diagnostic method and apparatus
    Patent number: 8290688
    Abstract: An internal combustion engine includes an exhaust system, an oxygen sensor in the exhaust system and a sensor malfunction monitor. In order to maintain operation during a fuel cut-off situation, the sensor malfunction monitor is arranged to control the fuel cut-off sequencing.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: October 16, 2012
    Assignee: DENSO Corporation
    Inventor: Iain Watson
  • Exhaust gas oxygen sensor diagnostic method and apparatus
    Publication number: 20110054764
    Abstract: An internal combustion engine includes an exhaust system, an oxygen sensor in the exhaust system and a sensor malfunction monitor. In order to maintain operation during a fuel cut-off situation, the sensor malfunction monitor is arranged to control the fuel cut-off sequencing.
    Type: Application
    Filed: September 1, 2009
    Publication date: March 3, 2011
    Applicant: DENSO Corporation
    Inventor: Iain Watson
  • Deterioration diagnosis system for exhaust gas sensor
    Patent number: 7387011
    Abstract: A diagnosis device calculates a lean-direction responsiveness characteristic and a rich-direction responsiveness characteristic of the exhaust gas sensor. The lean-direction responsiveness represents a responsiveness of the sensor in a case that an air-fuel ratio is controlled in such a manner as to be varied in a lean direction. The rich-direction responsiveness represents a responsiveness of the sensor in a case that the air-fuel ratio is controlled in such a manner as to be varied in a rich direction. The diagnosis device determines whether the exhaust gas sensor deteriorates based on at least one of the lean-direction responsiveness characteristic and the rich-direction responsiveness characteristic, and on a comparison result between the lean-direction responsiveness characteristic and the rich-direction responsiveness characteristic.
    Type: Grant
    Filed: March 28, 2007
    Date of Patent: June 17, 2008
    Assignee: Denso Corporation
    Inventors: Kenichi Fujiki, Yoshinori Maegawa, Jonathan Saunders, Iain Watson
  • Deterioration diagnosis system for exhaust gas sensor
    Publication number: 20070227124
    Abstract: A diagnosis device calculates a lean-direction responsiveness characteristic and a rich-direction responsiveness characteristic of the exhaust gas sensor. The lean-direction responsiveness represents a responsiveness of the sensor in a case that an air-fuel ratio is controlled in such a manner as to be varied in a lean direction. The rich-direction responsiveness represents a responsiveness of the sensor in a case that the air-fuel ratio is controlled in such a manner as to be varied in a rich direction. The diagnosis device determines whether the exhaust gas sensor deteriorates based on at least one of the lean-direction responsiveness characteristic and the rich-direction responsiveness characteristic, and on a comparison result between the lean-direction responsiveness characteristic and the rich-direction responsiveness characteristic.
    Type: Application
    Filed: March 28, 2007
    Publication date: October 4, 2007
    Applicant: Denso Corporation
    Inventors: Kenichi Fujiki, Yoshinori Maegawa, Jonathan Saunders, Iain Watson